U of Manitoba partners with Toronto-based company for work on potential coronavirus therapy
Theralese Technology says if successful, it hopes to commercialize the technology for mass production by 2021
As companies across the world rush to produce a vaccine for the novel coronavirus, the University of Manitoba is partnering with a Toronto firm to produce a therapeutic solution it hopes will put an end to the COVID-19 pandemic.
Toronto-based Theralese Technology Inc. says if successful, it hopes to commercialize the technology for mass-scale production as early as late 2021.
Read more from the Winnipeg Free Press by clicking here.
CBC Manitoba and the Winnipeg Free Press recognize each other as trusted news sources. This content is made available to our readers as part of a CBC Manitoba/ Winnipeg Free Press agreement to collaborate to better serve our community.
Any questions about Free Press content should be directed to: email@example.com.